Cargando…
Heterogeneous treatment effects of adjuvant therapy for patients with cervical cancer in the intermediate‐risk group
BACKGROUND: The efficacy of adjuvant therapy for patients with cervical cancer with intermediate risk (CC‐IR) remains controversial. We examined the impact of adjuvant therapy on survival outcomes in patients with CC‐IR and evaluated the heterogeneous treatment effects (HTEs) of adjuvant therapies b...
Autores principales: | Taguchi, Ayumi, Kato, Kosuke, Hara, Konan, Furusawa, Akiko, Nakajima, Yujiro, Ishizawa, Chihiro, Tanikawa, Michihiro, Sone, Kenbun, Mori, Mayuyo, Shimada, Muneaki, Okamoto, Aikou, Takekuma, Munetaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557871/ https://www.ncbi.nlm.nih.gov/pubmed/37584239 http://dx.doi.org/10.1002/cam4.6460 |
Ejemplares similares
-
Effect of pelvic radiotherapy on patients with stage IB‑IIA cervical cancer after radical hysterectomy: A single‑center retrospective study
por: Ishizawa, Chihiro, et al.
Publicado: (2023) -
Carcinogenesis and management of human papillomavirus-associated cervical cancer
por: Kusakabe, Misako, et al.
Publicado: (2023) -
Efficacy of regional cooling + oral dexamethasone for primary prevention of hand-foot syndrome associated with pegylated liposomal doxorubicin
por: Nara, Katsuhiko, et al.
Publicado: (2023) -
A case of difficult‐to‐diagnose non‐invasive papillary squamous cell carcinoma of the uterine cervix infected with human papilloma virus 6: A diagnostic pitfall
por: Sone, Kenbun, et al.
Publicado: (2021) -
Targeting Epigenetic Regulators for Endometrial Cancer Therapy: Its Molecular Biology and Potential Clinical Applications
por: Inoue, Futaba, et al.
Publicado: (2021)